Could an Outbreak Test Identify the Drug Behind One Patient’s Slow Pulse?
A laboratory can identify compounds circulating in an outbreak without establishing which one a particular patient took. Sud and colleagues reviewed 141 emergency visits for suspected synthetic cannabinoid intoxication. Some patients accounted for more than one visit.
What the clinical and laboratory records showed
Clinicians recorded lethargy or loss of consciousness in 68% of visits and bradycardia in 24%. The researchers analyzed subsets of product, blood and urine samples and detected synthetic cannabinoids or suspected metabolites in some. The samples were collected anonymously without designation to a specific patient. That prevented the researchers from identifying which bradycardic patients had particular positive findings.
What a patient-specific link requires
Ask whether the result can be matched to the patient’s specimen and collection time. A product provided by a patient can establish the contents of that submitted sample. Separate evidence is needed to connect it to ingestion and the symptoms observed. An outbreak pattern can generate a hypothesis without supplying that link for an individual visit.
